<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">O’Neil, Patrick</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Liraglutide Leads to Increased Weight Loss Response in Patients Without Diabetes</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-05-18 15:35:54</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">13-14</style></pages><abstract><style  face="normal" font="default" size="100%">Indicated for use in patients who were overweight (body mass index ≥ 27 kg/m2 with ≥ 1 comorbidities) or obese (body mass index ≥ 30 kg/m2) without diabetes mellitus, liraglutide has proven safe and effective in the SCALE–Obesity and Prediabetes trial. Combined with diet and exercise, liraglutide can improve weight and health-related quality-of-life factors.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>